Three pot stocks to explore as industry gets high on demand

August 10, 2021 01:06 PM PDT | By Team Kalkine Media
Follow us on Google News:

Summary

  • Cronos Group Inc (Nasdaq: CRON) reported revenue of US$15.62 million in Q2 this year.
  • Village Farms International, Inc.’s (Nasdaq: VFF) market cap is US$792 million.
  • Tilray Inc (Nasdaq: TLRY) reported a net loss of US$367.4 million in Q2 this year.

Cannabis stocks are companies that are into research and development and sale of cannabis products. In addition, the companies that support operations related to the marijuana industry also fall in this category.

On July 14, three Democratic senators had unveiled a draft bill to legalize marijuana at the federal level. The bill, if passed, will remove cannabis from the federal banned substance list. Besides, marijuana companies would be able to access bank services like loans, account opening, tax deductions, etc.

Eighteen states have already legalized cannabis for recreational use and 37 states for medical purposes.

Here we look at the marijuana stocks that may benefit from the move.


 

Source: Pixabay.

Also read: Top pot stocks to explore as US cannabis market booms

Cronos Group Inc (Nasdaq: CRON)

The stock of this cannabinoid company traded at US$7.09 at 12.35 pm ET on August 10, down 1.66 percent from the closing price of August 9. The stock value of CRON went up by 0.45 percent YTD.

The market capitalization of the Canada-based company is US$2.6 billion. The forward P/E one year is -24.90. The earnings per share (EPS) is US$-0.41. The highest and lowest stock price of the cannabis research company for 52 weeks is US$15.83 and US$4.92. The share volume is 888,710.

The total revenue of the pharmaceutical company for Q2 was US$15.62 million against US$9.88 million of Q2 last year. The net income for the period was US$57.05 against a net loss of US$106.98 million in Q2 last year.

Village Farms International, Inc. (Nasdaq: VFF)

The stock was priced at US$9.73 at 12.48 pm ET on August 10, down 2.01 percent from the previous close. The stock declined 4.65 percent YTD.

The total revenue of this Canada-based company for Q2 was US$70.37 million versus US$47.57 million of Q2 last year. The net loss in Q2 this year was US$4.52 million against a loss of US$0.12 million in Q2 last year.

The market cap of VFF is US$792 million. The forward P/E one year is -198.60, and the EPS is US$-0.04. The highest and lowest stock price of the company for the last 52 weeks was US$20.32 and US$4.27. Its share volume is 370,670.

Also read: 5 hot marijuana stocks to watch

Jazz Pharmaceuticals plc (Nasdaq: JAZZ)

The stock of cannabis-based drugmaker was priced at US$144.98 at 12.56 pm ET on August 10, down 3.97 percent from the closing price of August 9. The stock value of JAZZ went down by 12.52 percent YTD.

The total revenue of the Ireland-based firm in the second quarter this year was US$751 million compared to US$562 million in Q2 last year. Its net loss was US$363.3 million against a net income of US$114.8 million in Q2 last year.

The market capitalization of this pharmaceutical company is US$8.8 billion. The P/E ratio is 152.05 and the forward P/E one year is 12.74. The EPS is US$0.95. The 52-week highest and the lowest stock price of JAZZ was US$189 and US$119.08. The share volume is 566,800.

Tilray Inc (Nasdaq: TLRY)

The stock of this cannabis company traded at US$14.62 at 1.07 pm ET on August 10, down 0.68 percent from the closing price of August 9. The stock value of TLRY surged by 76.85 percent YTD.

The total revenue of the cannabis medical research company for Q2 this year was US$513.1 million against US$50.4 million in Q2 last year. The net loss was US$367.4 million compared to a loss of US$81.7 million last year.

The market capitalization of the Canada-based company is US$6.5 billion. The forward P/E one year is -105.07, and the EPS is US$-1.87.

The highest and lowest stock price of TLRY for the last 52 weeks is US$67 and US$4.41. The share volume is 9,485,090.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.



Top Listed Companies